Equities analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will post $123.07 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $119.13 million to $125.10 million. U.S. Physical Therapy posted sales of $83.86 million during the same quarter last year, which would indicate a positive year over year growth rate of 46.8%. The company is expected to report its next quarterly earnings report on Thursday, August 5th.
According to Zacks, analysts expect that U.S. Physical Therapy will report full year sales of $482.35 million for the current year, with estimates ranging from $470.25 million to $488.40 million. For the next fiscal year, analysts anticipate that the business will post sales of $511.03 million, with estimates ranging from $501.94 million to $519.60 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for U.S. Physical Therapy.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, May 6th. The company reported $0.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.17. U.S. Physical Therapy had a return on equity of 14.19% and a net margin of 7.73%. The firm had revenue of $112.37 million during the quarter, compared to analysts’ expectations of $110.36 million. During the same quarter last year, the firm earned $0.30 EPS. The business’s quarterly revenue was down .3% on a year-over-year basis.
In other news, COO Graham D. Reeve sold 1,819 shares of the business’s stock in a transaction that occurred on Friday, May 7th. The stock was sold at an average price of $117.99, for a total value of $214,623.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Edward L. Kuntz sold 1,600 shares of the stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $121.73, for a total value of $194,768.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,669 shares of company stock valued at $1,158,022. Company insiders own 1.80% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. ProShare Advisors LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $367,000. Wasatch Advisors Inc. grew its holdings in U.S. Physical Therapy by 51.3% in the 1st quarter. Wasatch Advisors Inc. now owns 258,037 shares of the company’s stock valued at $26,862,000 after buying an additional 87,462 shares in the last quarter. Engineers Gate Manager LP acquired a new stake in shares of U.S. Physical Therapy in the 4th quarter worth $889,000. Truist Financial Corp increased its stake in shares of U.S. Physical Therapy by 19.0% in the 4th quarter. Truist Financial Corp now owns 10,082 shares of the company’s stock worth $1,213,000 after acquiring an additional 1,612 shares during the last quarter. Finally, Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the 4th quarter valued at about $1,500,000. 97.78% of the stock is currently owned by institutional investors.
Shares of USPH stock traded down $0.77 during trading hours on Monday, reaching $118.98. 235 shares of the company’s stock were exchanged, compared to its average volume of 68,144. U.S. Physical Therapy has a 1 year low of $70.97 and a 1 year high of $143.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.83 and a current ratio of 0.83. The stock has a market cap of $1.53 billion, a PE ratio of 48.09 and a beta of 1.46. The firm has a fifty day moving average price of $114.30.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 11th. Stockholders of record on Friday, May 14th will be paid a dividend of $0.35 per share. The ex-dividend date of this dividend is Thursday, May 13th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.18%. U.S. Physical Therapy’s payout ratio is 46.82%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading: Insider Trading – What You Need to Know
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.